Concepedia

Takeyuki Iwata

TI

4

Publications

273

Citations

4

H-Index

2004

Active since

Affiliations

Ono Pharmaceutical (Japan)(Current)

Takeyuki Iwata is an author at Ono Pharmaceutical (Japan) specializing in medicine, hepatology, and hepatocellular carcinoma.

Top concepts

MedicineHepatologyHepatocellular CarcinomaLiverHealthPathologyCell BiologyPharmacologyOrganogenesisCell Signaling

Publications per year

2004–2020

4

Publications

4

Suppression of C/EBPα expression in periportal hepatoblasts may stimulate biliary cell differentiation through increased<i>Hnf6</i>and<i>Hnf1b</i>expression

Harufumi Yamasaki, Aiko Sada, Takeyuki Iwata et al. · Development · 2006 · 98 citations · Full text

Pathology, Organ Development, Cholangiopathies +18

A phase Ib study of lenvatinib (LEN) plus nivolumab (NIV) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study 117.

Masatoshi Kudo, Masafumi Ikeda, Kenta Motomura et al. · Journal of Clinical Oncology · 2020 · 92 citations

Immunohematology, Pathology, Pharmacotherapy +24

Suppression of C/EBP α expression in biliary cell differentiation from hepatoblasts during mouse liver development

Nobuyoshi Shiojiri, Kentaro Takeshita, Harufumi Yamasaki et al. · Journal of Hepatology · 2004 · 49 citations

C/ebp α Expression, Cholangiopathies, Cholangiocyte Biology +16

Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism

Yukina Fukuchi, Kota Toshimoto, Takanori Mori et al. · Journal of Pharmaceutical Sciences · 2017 · 34 citations

Nonlinear Pharmacokinetics, Pharmacokinetic Modeling, Biochemistry +7

Rows per page

1–4 of 4